The online version of this article (doi:10.1186/1475-2875-11-66) contains supplementary material, which is available to authorized users.
The authors declare that they have no competing interests.
JCK was a graduate student in Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya. He conducted all the experiments, helped in data analysis and drafted the manuscript. Both JKM were university supervisors to JCK and assisted in study design and edited the manuscript. JNW designed the study, supervised the work and helped in drafting the final manuscript. All authors have read and approved the final manuscript.
Recent studies implicate deficiency of red blood cell (RBC) complement regulatory proteins (CR1 and CD55) in the pathogenesis of malarial anaemia. This study explored the involvement of B cell CD21, which has an analogous role to RBC CR1.
In a case control study conducted in Kisumu District hospital, western Kenya, children with severe malaria anaemia (SMA) and those with uncomplicated malaria (UM) were assessed by flow cytometry for B cells (CD20+) numbers, expression levels of CD21 and deposition of C3dg and by ELISA for soluble CD21 (sCD21). Paired t tests were used to determine statistical significance at a = 0.05.
Children with SMA had significantly higher lymphocyte count (9,627.7 ± 8786.1 SD vs. 5,507 ± 2436 SD, P = 0.04 in the UM group) and the computed geometric mean of mature B-cell numbers based on the absolute lymphocyte count was significantly higher for SMA group: 1,823 (1,126 to 2,982, 95% CI) and 826.6 (564 to 1,220, 95% CI)] for UM group (P = 0.003). SMA group also had a higher percentage of CD20+ B cells (26.8 ± 9.7SD vs 20.9 ± 9.01 SD in the UM) (P = 0.03), indicating considerable polyclonal B-cell activation. The CD21 median flourescence intensity was lower in the SMA (246.4 ± 87.4 SD vs 369 ± 137.7 SD) (P < 0.0001), probably due to complement mediated shaving of CD21 by fixed tissue macrophages. The CD20+ B cells of SMAs had higher levels of the complement split product C3dg (18.35 ± 10 SD vs 11.5 ± 6.8 S.D), (P = 0.0002), confirming possible role of complement in CD21 removal. Unexpectedly, the SMAs had lower levels of sCD21 (226.5 ± 131.5 SD vs 341.4 ± 137.3 SD in the UM) (P < 0.0001), indicating that the shaved CD21 is not released to peripheral circulation.
These results implicate B-cell in pathophysiology of severe malaria that involves increased B-cell proliferation, increased complement deposition and subsequent loss of membrane-bound CD21. The loss of CD21 is not by the classical enzmatic cleavage.
Authors’ original file for figure 112936_2011_2036_MOESM1_ESM.pdf
Authors’ original file for figure 212936_2011_2036_MOESM2_ESM.pdf
Authors’ original file for figure 312936_2011_2036_MOESM3_ESM.doc
Authors’ original file for figure 412936_2011_2036_MOESM4_ESM.doc
Authors’ original file for figure 512936_2011_2036_MOESM5_ESM.doc
WHO: World malaria report 2008. 2008, Geneva: World Health Organization
Waitumbi JN, Opollo MO, Muga RO, Misore AO, Stoute JA: Red cell surface changes and erythrophagocytosis in children with severe Plasmodium falciparum anemia. Blood. 2000, 95: 1481-1486. PubMed
Thornton BP, Vetvicka V, Ross GD: Function of C3 in a humoral response: iC3b/C3dg bound to an immune complex generated with natural antibody and a primary antigen promotes antigen uptake and the expression of co-stimulatory molecules by all B cells, but only stimulates immunoglobulin synthesis by antigen-specific B cells. Clin Exp Immunol. 1996, 104: 531-537. 10.1046/j.1365-2249.1996.57761.x. PubMedCentralCrossRefPubMed
Thornton BP, Vetvicka V, Ross GD: Natural antibody and complement-mediated antigen processing and presentation by B lymphocytes. J Immunol. 1994, 152: 1727-1737. PubMed
Boyd AW, Anderson KC, Freedman AS, Fisher DC, Slaughenhoupt B, Schlossman SF, Nadler LM: Studies of in vitro activation and differentiation of human B lymphocytes. I. Phenotypic and functional characterization of the B cell population responding to anti-Ig antibody. J Immunol. 1985, 134: 1516-1523. PubMed
Myones BL, Ross GD: Identification of a spontaneously shed fragment of B cell complement receptor type two (CR2) containing the C3d-binding site. Complement. 1987, 4: 87-98. PubMed
Abele DC, Tobie JE, Hill GJ, Contacos PG, Evans CB: Alterations in Serum Proteins and 19s Antibody Production during the Course of Induced Malarial Infections in Man. Am J Trop Med Hyg. 1965, 14: 191-197. PubMed
Tobie JE, Abele DC, Wolff SM, Contacos PG, Evans CB: Serum immunoglobulin levels in human malaria and their relationship to antibody production. J Immunol. 1966, 97: 498-505. PubMed
Prodinger WM, Schwendinger MG, Schoch J, Kochle M, Larcher C, Dierich MP: Characterization of C3dg binding to a recess formed between short consensus repeats 1 and 2 of complement receptor type 2 (CR2; CD21). J Immunol. 1998, 161: 4604-4610. PubMed
Masilamani M, Nowack R, Witte T, Schlesier M, Warnatz K, Glocker MO, Peter HH, Illges H: Reduction of soluble complement receptor 2/CD21 in systemic lupus erythomatosus and Sjogren's syndrome but not juvenile arthritis. Scand J Immunol. 2004, 60: 625-630. 10.1111/j.0300-9475.2004.01494.x. CrossRefPubMed
Masilamani M, von Kempis J, Illges H: Decreased levels of serum soluble complement receptor-II (CR2/CD21) in patients with rheumatoid arthritis. Rheumatology (Oxford). 2004, 43: 186-190. CrossRef
- B-cell activity in children with malaria
Jackson C Korir
Japhet K Magambo
Joseph K Mwatha
John N Waitumbi
- BioMed Central
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
e.Med Kampagnen-Visual, Mail Icon II